Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
This study is looking at people who are already having a diagnostic right heart catheterization (RHC) procedure. Researchers will collect data from a device called HemoCept during this procedure. The main goal is to see how well the measurements from the HemoCept device match up with a measurement called Pulmonary Capillary Wedge Pressure (a way to check heart function) on the day of your procedure. This study is open to adults aged 18 and older. The study plans to include about 50 participants, but its current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will collect information without giving you any new treatments. It plans to enroll about 50 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The main measurement for this study is taken on Day 1.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Association between device measurements and Pulmonary Capillary Wedge PressureDay 1
The correlation of HemoCept device measurements to Pulmonary Capillary Wedge Pressure (PCWP) measured during right heart catheterization.